Doximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) P/B ratio
As of 5 November 2026, Doximity, Inc. (DOCS) trades at a P/B ratio of 6.4×. Over the past ten years it has ranged from 3.5× (May 2026) to 65.0× (June 2021); the current reading is higher than 38% of that period. That is above the Health Information Services industry median of 1.9× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2026 | 4.6× | (54.24%) |
| FY2025 | 10.0× | 79.74% |
| FY2024 | 5.6× | (13.94%) |
| FY2023 | 6.5× | (33.20%) |
| FY2022 | 9.7× | (83.58%) |
| FY2021 | 59.0× | 0.00% |
| FY2020 | 59.0× | 0.00% |
| FY2019 | 59.0× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 5.5× | 31.94% |
| Jun 2026 | 4.1× | (9.80%) |
| Mar 2026 | 4.6× | (45.94%) |
| Dec 2025 | 8.5× | (32.36%) |
| 23 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| WAY Waystar Holding Corp. compare | 1.4× |
| PRVA Privia Health Group, Inc. compare | 3.5× |
| HQY HealthEquity, Inc. compare | 4.3× |
| BTSG BrightSpring Health Services, Inc. compare | 6.3× |
| DOCS Doximity, Inc. | 6.4× |
| SDGR Schrodinger, Inc. compare | 7.2× |
| HTFL Heartflow, Inc. compare | 16.1× |
| TEM Tempus AI, Inc. compare | 25.5× |
| HNGE Hinge Health Inc. compare | 26.6× |
| Health Information Services industry median | 1.9× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on DOCS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement